Citicoline eye drops 2% for glaucoma, open-angle

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Feb 2023: Trial registered, NCT05710198
  2. 11 Dec 2023: Trial started, NCT05710198

The trials

NCT05710198: Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma

State
Under way
Phase
Phase 3
People
873 taking part
Started
11 Dec 2023
Primary completion
1 Jul 2029
Arms
citicoline eye drops 2%
Results
None posted
  1. 2 Feb 2023: Trial registered
  2. 11 Dec 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.